Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Bayer, Bristol-Myers, Ono Partner for Colorectal Cancer Study

Bayer, Bristol-Myers Squibb and Ono Pharmaceutical teamed up to study the most common type of metastatic colorectal cancer.

Read More »

Genmab Raises $506 Million in IPO

Copenhagen, Denmark-based Genmab A/S raised $506 million with an initial public offering (IPO), with the company trading on the Nasdaq under the ticker symbol GMAB.

Read More »

China Has Big Presence in Top 10 Biotech IPOs in 2019

New rules went into effect during 2018 on the Hong Kong stock exchange allowing companies that did not have a product on the market or generate revenue to list on the exchange.

Read More »

Inovio, Amneal Slash Workforce as Both Companies Undergo Realignments

Inovio Pharmaceuticals is terminating 28 percent of the company’s workforce, and Amneal Pharmaceuticals will cut 550 employees by the end of 2020.

Read More »

Three Senators Draft Bipartisan Resolution on CRISPR Gene Editing

Three U.S. senators introduced a resolution in support of a moratorium and other limits on gene editing embryos.

Read More »

Genentech Strikes Three Drug Discovery Deals

In a deal-making morning for South San Francisco-based Genentech, the Roche subsidiary struck three separate transactions with small companies to boost drug development.

Read More »

Artificial Intelligence-Focused Companies Advance Programming

Companies continue to announce advancements in artificial intelligence programming as they harness the power of AI and machine learning to aid in drug discovery and development.

Read More »

Biosimilars Struggle to Gain U.S. Market Share

Despite numerous FDA approvals of biosimilars, they have not yet gained a significant stake in the U.S. marketplace, according to a recent analysis published in Forbes.

Read More »

Gilead Appoints Christi L. Shaw as Chief Executive Officer of Kite

Gilead Sciences Inc. announced that Christi L. Shaw will join the company as CEO of subsidiary Kite Pharma and will become a member of Gilead’s senior leadership team.

Read More »

Reckitt Benckiser Settles Indivior Opioid Investigation

Reckitt Benckiser Group agreed to pay $1.4 billion to settle a U.S. investigation into the sales and marketing of Suboxone Film, a product managed by the spinout company Indivior.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!

Subscribe

Ad Right Bottom